Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 4
2005 2
2008 1
2009 2
2010 3
2011 6
2012 4
2013 13
2014 8
2015 10
2016 13
2017 20
2018 8
2019 9
2020 28
2021 30
2022 21
2023 19
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

186 results

Results by year

Filters applied: . Clear all
Page 1
DLL3 as an Emerging Target for the Treatment of Neuroendocrine Neoplasms.
Yao J, Bergsland E, Aggarwal R, Aparicio A, Beltran H, Crabtree JS, Hann CL, Ibrahim T, Byers LA, Sasano H, Umejiego J, Pavel M. Yao J, et al. Among authors: ibrahim t. Oncologist. 2022 Nov 3;27(11):940-951. doi: 10.1093/oncolo/oyac161. Oncologist. 2022. PMID: 35983951 Free PMC article. Review.
Trends in Bone Metastasis Modeling.
Laranga R, Duchi S, Ibrahim T, Guerrieri AN, Donati DM, Lucarelli E. Laranga R, et al. Among authors: ibrahim t. Cancers (Basel). 2020 Aug 17;12(8):2315. doi: 10.3390/cancers12082315. Cancers (Basel). 2020. PMID: 32824479 Free PMC article. Review.
A global collaboRAtive study of CIC-rearranged, BCOR::CCNB3-rearranged and other ultra-rare unclassified undifferentiated small round cell sarcomas (GRACefUl).
Palmerini E, Gambarotti M, Italiano A, Nathenson MJ, Ratan R, Dileo P, Provenzano S, Jones RL, DuBois SG, Martin-Broto J, de Alava E, Baldi GG, Grignani G, Ferraresi V, Brunello A, Paoluzzi L, Bertulli R, Hindi N, Montemurro M, Rothermundt C, Cocchi S, Salguero-Aranda C, Donati D, Martin JD, Abdelhamid Ahmed AH, Mazzocca A, Carretta E, Cesari M, Pierini M, Righi A, Sbaraglia M, Laginestra MA, Scotlandi K, Dei Tos AP, Ibrahim T, Stacchiotti S, Vincenzi B. Palmerini E, et al. Among authors: ibrahim t. Eur J Cancer. 2023 Apr;183:11-23. doi: 10.1016/j.ejca.2023.01.003. Epub 2023 Jan 18. Eur J Cancer. 2023. PMID: 36791667
Modeling Myxofibrosarcoma: Where Do We Stand and What Is Missing?
Lucarelli E, De Vita A, Bellotti C, Frisoni T, Vanni S, Guerrieri AN, Pannella M, Mercatali L, Gambarotti M, Duchi S, Miserocchi G, Maioli M, Liverani C, Ibrahim T. Lucarelli E, et al. Among authors: ibrahim t. Cancers (Basel). 2023 Oct 25;15(21):5132. doi: 10.3390/cancers15215132. Cancers (Basel). 2023. PMID: 37958307 Free PMC article. Review.
Bone and cancer: the osteoncology.
Ibrahim T, Mercatali L, Amadori D. Ibrahim T, et al. Clin Cases Miner Bone Metab. 2013 May;10(2):121-3. Clin Cases Miner Bone Metab. 2013. PMID: 24133529 Free PMC article. Review.
The emerging role of cancer nanotechnology in the panorama of sarcoma.
Mercatali L, Vanni S, Miserocchi G, Liverani C, Spadazzi C, Cocchi C, Calabrese C, Gurrieri L, Fausti V, Riva N, Genovese D, Lucarelli E, Focarete ML, Ibrahim T, Calabrò L, De Vita A. Mercatali L, et al. Among authors: ibrahim t. Front Bioeng Biotechnol. 2022 Oct 17;10:953555. doi: 10.3389/fbioe.2022.953555. eCollection 2022. Front Bioeng Biotechnol. 2022. PMID: 36324885 Free PMC article. Review.
Strategies to Overcome Resistance to Immune-Based Therapies in Osteosarcoma.
Hattinger CM, Salaroglio IC, Fantoni L, Godel M, Casotti C, Kopecka J, Scotlandi K, Ibrahim T, Riganti C, Serra M. Hattinger CM, et al. Among authors: ibrahim t. Int J Mol Sci. 2023 Jan 2;24(1):799. doi: 10.3390/ijms24010799. Int J Mol Sci. 2023. PMID: 36614241 Free PMC article. Review.
186 results